Impact of the 2013 WHO guidelines for screening and treatment of cervical pre-cancerous lesions on women’s screening uptake, by HIV-status, in Eastern and Southern Africa: a regression discontinuity design analysis
We found no evidence the 2013 WHO guidelines impacted women's cervical pre-cancer screening uptake. However, AGYWLHIV reported screening less often. Policymakers should lower the age to screen WLHIV from 25 to 15 to screen more AGYWLHIV. Studies are required to examine the impact of the guidelines on cervical pre-cancer screening in more countries.
Authors
- Janne Estill (ORCID: https://orcid.org/0000-0001-9544-1447)
- Connie Osborne
- Silas Amo-Agyei (ORCID: https://orcid.org/0000-0001-9718-6363)
- Julia Bohlius (ORCID: https://orcid.org/0000-0003-1955-1585)
- Ani Shakarishvilia
- Alinane Linda Nyondo-Mipando
- David Chipanta
- Olivia Keiser
Institutions
- University of Geneva (CH)
- Joint United Nations Programme on HIV/AIDS (CH)
- Swiss Tropical and Public Health Institute (CH)
- University of Basel (CH)
- Kamuzu Central Hospital (MW)
- University of Manchester (GB)
- National HIV/AIDS/STI/TB Council (ZM)
- Kamuzu University of Health Sciences (MW)
Publication Details
- Journal
- Reproductive Health
- Published
- 2026-02-19
- DOI
- https://doi.org/10.1186/s12978-026-02274-4
- Primary Topic
- Cervical Cancer and HPV Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00